Clinical Application of Umbilical Cord Mesenchymal Stem Cells Preserves β-cells in Type 1 Diabetes
Stem Cells Translational Medicine · 2024
DOI: 10.1093/stcltm/szad077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2024. Verfasst von Ashraf Al Madhoun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Wharton Jelly, Mesenchymal Stem Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Kuwait Foundation for Advancement of Sciences.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 1 diabetes (T1D) is a chronic autoimmune disease associated with complications that reduce the quality of life of affected individuals and their families. The therapeutic options for T1D are limited to insulin therapy and islet transplantation; these options are not focused on preserving β-cell function and endogenous insulin. Despite the promising outcomes observed in current clinical trials involving allogeneic Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) infusion for the management of T1D, the precise underlying mechanism of action remains to be elucidated. In this correspondence, we propose prospective mechanisms of action of WJ-MSCs that may be mediating their observed capability to preserve β-cell function and prevent T1D progression and provide recommendations for further investigations in clinical settings. We also highlight the efficacy of WJ-MSCs for therapeutic applications in comparison to other adult MSCs. Finally, we recommend the participation of muti-centers governed by international organizations to implement guidelines for the safe practice of cell therapy and patients’ welfare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.
- Department of Periodontology, Universitat Internacional de Catalunya (UIC), C/Josep Trueta s/n, Sant Cugat del Valles, 08195 Barcelona, Spain.
- Biointelligent Technology Systems SL, C/Diputaccion 316, 3D, 08009 Barcelona, Spain.
ORCID-Profile: Ashraf Al Madhoun
Förderung
- Kuwait Foundation for Advancement of Sciences
Zitieren
APA
Al Madhoun, A., Koti, L., Carrió, N., Atari, M., & Al-Mulla, F. (2024). Clinical Application of Umbilical Cord Mesenchymal Stem Cells Preserves β-cells in Type 1 Diabetes. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szad077
Vancouver
Al Madhoun A, Koti L, Carrió N, Atari M, Al-Mulla F. Clinical Application of Umbilical Cord Mesenchymal Stem Cells Preserves β-cells in Type 1 Diabetes. Stem Cells Translational Medicine. 2024. doi:10.1093/stcltm/szad077
BibTeX
@article{AlMadhoun2024,
author = {Al Madhoun, Ashraf and Koti, Lubaina and Carrió, Neus and Atari, Maher and Al-Mulla, Fahd},
title = {Clinical Application of Umbilical Cord Mesenchymal Stem Cells Preserves β-cells in Type 1 Diabetes},
journal = {Stem Cells Translational Medicine},
year = {2024},
doi = {10.1093/stcltm/szad077}
}
EUVIMED